Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding

  • Post date May 4, 2022 — 23:29 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002773 300713 Chengdu Kanghong Pharmaceutical Group China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Human Resources Management Strategy, Marketing Annual, Special Corporate Meeting Annual Report Patent, Copyright, Trademark Research, Development Health, Beauty Product Pharmaceutical Synthetic, Plastic Chemicals Construction, Property Insurance Market, Exchange Diseases, Conditions Medicine Therapy Health Insurance Workplace Health, Safety Trend Oncology Ophthalmology Surgery Economy, Business, Finance Environment Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data